EHC:NYE-Encompass Health Corp (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 120.87

Change

0.00 (0.00)%

Market Cap

USD 10.29B

Volume

0.90M

Analyst Target

USD 86.07
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-17 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

N/A

USD 82.48B
THC Tenet Healthcare Corporation

N/A

USD 15.37B
UHS Universal Health Services Inc

N/A

USD 12.76B
DVA DaVita HealthCare Partners Inc

N/A

USD 11.16B
CHE Chemed Corp

N/A

USD 8.48B
CON Concentra Group Holdings Paren..

N/A

USD 2.93B
ARDT Ardent Health Partners, Inc.

N/A

USD 2.59B
AGL agilon health Inc

N/A

USD 1.65B
NHC National HealthCare Corporatio..

N/A

USD 1.42B
GRDN Guardian Pharmacy Services, In..

N/A

USD 1.25B

ETFs Containing EHC

GLRY Inspire Faithward Mid Cap.. 3.25 % 0.00 %

N/A

USD 0.08B
HLTH:AU VanEck Global Healthcare .. 2.31 % 0.00 %

N/A

USD 0.06B
JPSV Jpmorgan Active Small Cap.. 1.67 % 0.00 %

N/A

USD 0.02B
FDLS Northern Lights Fund Trus.. 1.15 % 0.00 %

N/A

USD 0.07B
USVM VictoryShares US Small Mi.. 0.70 % 0.25 %

N/A

USD 0.77B
UIMS:XETRA UBS (Irl) ETF plc - UBS (.. 0.64 % 0.00 %

N/A

USD 0.07B
WSCSRI:SW UBS (Irl) ETF plc - UBS (.. 0.64 % 0.00 %

N/A

USD 0.50B
WSCR:LSE UBS (Irl) ETF plc - MSCI .. 0.62 % 0.00 %

N/A

USD 0.02B
OSCV Opus Small Cap Value Plus 0.00 % 0.79 %

N/A

USD 0.49B
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

N/A

USD 0.09B
SIXL 6 Meridian Low Beta Equit.. 0.00 % 0.00 %

N/A

USD 0.19B
ISCG iShares Morningstar Small.. 0.00 % 0.00 %

N/A

USD 0.61B
DFAS Dimensional U.S. Small Ca.. 0.00 % 0.00 %

N/A

USD 8.57B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 30.88% 81% B- 96% N/A
Dividend Return 0.18% 50% F 4% F
Total Return 31.07% 81% B- 96% N/A
Trailing 12 Months  
Capital Gain 41.45% 91% A- 94% A
Dividend Return 0.57% 38% F 9% A-
Total Return 42.02% 91% A- 94% A
Trailing 5 Years  
Capital Gain 116.99% 88% B+ 79% B-
Dividend Return 6.47% 38% F 14% F
Total Return 123.45% 88% B+ 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 10.10% 52% F 70% C-
Dividend Return 11.28% 57% F 68% D+
Total Return 1.18% 56% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 26.93% 74% C 35% F
Risk Adjusted Return 41.87% 83% B 58% F
Market Capitalization 10.29B 81% B- 86% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector